In early 2026, the “new” COVID vaccines for the 2025–2026 season are already out in many places, but exact availability depends on your country, your age, and your risk factors.

Quick Scoop: What’s out now?

  • For the U.S., the FDA told manufacturers to update to a JN.1‑lineage formula for use starting fall 2025 , and those updated 2025–2026 shots are now in use as of the current season.
  • Moderna’s updated Spikevax 2025–2026 formula is listed as “now available” for older adults and younger people at high risk, with a locator to find sites.
  • A protein‑based, non‑mRNA Novavax Nuvaxovid 2025–2026 formula has been approved in the U.S. for people 65+ and for ages 12–64 with at least one high‑risk condition.
  • National health agencies (for example, Australia) report ongoing 2026 rollout updates , meaning doses and eligibility are being adjusted rather than waiting for a totally new product later in the year.

In practice, this means that if you are in a high‑risk group (older age, chronic conditions, or other risk factors), you can likely already access the latest updated vaccine for the 2025–2026 season or will be able to very soon, depending on local supply and guidelines.

How “new” vaccines typically roll out

  • Each year, experts review which variant is dominant (currently JN.1‑lineage and sub‑variants) and recommend a new monovalent formula, similar to how flu shots are updated.
  • Regulatory bodies (like the FDA or equivalents in other countries) then authorize or approve updated formulations from companies such as Pfizer‑BioNTech, Moderna, and Novavax, after which pharmacies and clinics begin offering them in late summer or fall.

A typical pattern (subject to change locally):

  1. Advisory committee picks the strain in late spring/early summer.
  1. Manufacturers finalize and submit updated vaccines over the summer.
  2. Vaccination campaigns start late summer or fall for the coming respiratory season.

What you should do right now

Because availability is both country‑specific and group‑specific , the best way to get an exact answer for you is to:

  1. Check your national or regional health authority website (e.g., health ministry, CDC‑equivalent, or NHS‑equivalent) for a “COVID‑19 vaccine 2025–2026” or “latest COVID vaccine” page.
  1. Use a vaccine locator from a major provider (large pharmacy chains, or company pages like Moderna’s Spikevax site) to see if local appointments exist for your age and risk group.
  1. Ask your GP or pharmacist specifically: “Do you have the 2025–2026 COVID vaccine and am I eligible for it now?”

Example: In many U.S. settings right now, a 70‑year‑old with heart disease would be eligible immediately for a 2025–2026 updated shot, while a healthy 25‑year‑old might only be eligible if guidelines include them or if extra stock is available.

Mini forum‑style note

People on health forums often ask “Is there a new COVID shot this year or is it the same one?” The key is that “new” usually means “updated to match the current variant,” not a completely different technology or a brand‑new long‑term solution. The 2025–2026 vaccines are updated JN.1‑lineage shots intended for this season’s waves.

TL;DR:
The latest “new” COVID vaccines for the 2025–2026 season (JN.1‑lineage formulations from Moderna, Pfizer‑BioNTech, and Novavax) are already approved and rolling out in multiple countries, especially for older adults and people at higher risk; check your local health authority or pharmacy to see if you personally can book an appointment now.

Information gathered from public forums or data available on the internet and portrayed here.